CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Ji Won Han, Su-Hyung Park
J Liver Cancer. 2021;21(2):139-145.   Published online September 30, 2021
DOI: https://doi.org/10.17998/jlc.2021.09.24

Excel Download

Immune checkpoint inhibitors for hepatocellular carcinoma
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022;215-223   Crossref logo
Link1 Link2

Immune Checkpoint Inhibitors for the Treatment of Hepatocellular Carcinoma
Immunotherapy of Hepatocellular Carcinoma. 2017;51-68   Crossref logo
Link1

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma. 2022;Volume 9:1217-1228   Crossref logo
Link1 Link2

Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
Frontiers in Immunology. 2022;13:   Crossref logo
Link1

Immunotherapy and Hepatocellular Carcinoma
Immune Checkpoint Inhibitors - New Insights and Recent Progress [Working Title]. 2022;   Crossref logo
Link1

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
The Oncologist. 2019;24(S1):S3-S10   Crossref logo
Link1 Link2 Link3 Link4

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
Cancers. 2020;12(5):1274   Crossref logo
Link1

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
Pharmaceuticals. 2020;14(1):3   Crossref logo
Link1

Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies
Frontiers in Oncology. 2022;12:   Crossref logo
Link1

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Cancers. 2021;13(17):4343   Crossref logo
Link1